Related Experiment Video
Updated: May 30, 2025

07:03
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023
799
Intricacies of human-AI interaction in dynamic decision-making for precision oncology
Dipesh Niraula1, Kyle C Cuneo2, Ivo D Dinov3
1Department of Machine Learning, Moffitt Cancer Center, Tampa, FL, USA. dipesh.niraula@moffitt.org.
Nature Communications
|January 29, 2025
Summary
Clinicians
Area of Science:
- Oncology
- Medical Informatics
- Artificial Intelligence in Medicine
Background:
- AI decision support systems offer personalized cancer care by adapting treatments to patient progression.
- Over-reliance or under-reliance on imperfect AI can result in suboptimal cancer therapeutics.
Purpose of the Study:
- To investigate the Human-AI interaction dynamics in AI-assisted adaptive radiotherapy for non-small cell lung cancer and hepatocellular carcinoma.
- To explore how clinicians collaborate with AI in treatment planning.
Main Methods:
- A Human-AI interaction study was conducted.
- Two levels of collaborative behavior were investigated: model-agnostic and model-specific.
- The study focused on response-adaptive radiotherapy for specific cancer types.
Main Results:
- Human-AI interaction is multifactorial, influenced by clinician's prior knowledge, patient state, disease site, and AI characteristics.
- Clinicians' trust and reliance on AI recommendations vary based on perceived benefit, harm, or model transparency.
- Clinicians may disregard, critically analyze, or adjust decisions based on AI recommendations.
Conclusions:
- Effective Human-AI collaboration in adaptive cancer treatment requires careful consideration of multiple influencing factors.
- Understanding clinician-AI interplay is crucial for optimizing AI's role in personalized cancer care.
- Clinicians' critical judgment remains essential in utilizing AI for therapeutic decision-making.
Related Concept Videos
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Ethical Dilemmas II
916
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
916
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K

